06/03/10 Philips and RXi Pharmaceuticals sign agreement to jointly research innovative image-guided therapy concepts based on RNAi
Philips and RXi Pharmaceuticals Corporation a US-based biopharmaceutical company announce that they have entered into a joint research agreement to explore the benefits of combining proprietary technologies from both companies for the targeted delivery of experimental therapeutics based on RNA interference (RNAi)…
